These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16707484)

  • 1. cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells.
    Fu X; Beer DG; Behar J; Wands J; Lambeth D; Cao W
    J Biol Chem; 2006 Jul; 281(29):20368-82. PubMed ID: 16707484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells.
    Si J; Fu X; Behar J; Wands J; Beer DG; Souza RF; Spechler SJ; Lambeth D; Cao W
    J Biol Chem; 2007 Jun; 282(22):16244-55. PubMed ID: 17403674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells.
    Si J; Behar J; Wands J; Beer DG; Lambeth D; Chin YE; Cao W
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G174-83. PubMed ID: 17947454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Rac1 in regulation of NOX5-S function in Barrett's esophageal adenocarcinoma cells.
    Hong J; Resnick M; Behar J; Wands J; DeLellis RA; Cao W
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C413-20. PubMed ID: 21525435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells.
    Zhou X; Li D; Resnick MB; Wands J; Cao W
    Mol Pharmacol; 2013 May; 83(5):978-90. PubMed ID: 23439561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells.
    Li D; Cao W
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G863-72. PubMed ID: 24699332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid receptor TGR5, NADPH Oxidase NOX5-S and CREB Mediate Bile Acid-Induced DNA Damage In Barrett's Esophageal Adenocarcinoma Cells.
    Li D; Cao W
    Sci Rep; 2016 Aug; 6():31538. PubMed ID: 27511066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S.
    Hong J; Behar J; Wands J; Resnick M; Wang LJ; Delellis RA; Lambeth D; Cao W
    Cancer Res; 2010 Feb; 70(3):1247-55. PubMed ID: 20086178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencer-of-Death Domain Mediates Acid-Induced Decrease in Cell Apoptosis in Barrett's Associated Esophageal Adenocarcinoma Cells.
    Li D; Hong J; Cao W
    J Pharmacol Exp Ther; 2017 Jan; 360(1):14-22. PubMed ID: 27756772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling in H2O2-induced increase in cell proliferation in Barrett's esophageal adenocarcinoma cells.
    Zhou X; Li D; Resnick MB; Behar J; Wands J; Cao W
    J Pharmacol Exp Ther; 2011 Oct; 339(1):218-27. PubMed ID: 21750116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S.
    Hong J; Resnick M; Behar J; Wang LJ; Wands J; DeLellis RA; Souza RF; Spechler SJ; Cao W
    Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G697-706. PubMed ID: 20576920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho Kinase ROCK2 Mediates Acid-Induced NADPH Oxidase NOX5-S Expression in Human Esophageal Adenocarcinoma Cells.
    Hong J; Li D; Cao W
    PLoS One; 2016; 11(2):e0149735. PubMed ID: 26901778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NADPH oxidase NOX5-S, NF-κB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells.
    Hong J; Li D; Wands J; Souza R; Cao W
    Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1069-79. PubMed ID: 24025864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma.
    Hong J; Behar J; Wands J; Resnick M; Wang LJ; DeLellis RA; Lambeth D; Souza RF; Spechler SJ; Cao W
    Gut; 2010 Feb; 59(2):170-80. PubMed ID: 19926617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Proton Pump Inhibitor Therapy on NOX5, mPGES1 and iNOS expression in Barrett's Esophagus.
    Li D; Deconda D; Li A; Habr F; Cao W
    Sci Rep; 2019 Nov; 9(1):16242. PubMed ID: 31700071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells.
    Yu P; Han W; Villar VA; Yang Y; Lu Q; Lee H; Li F; Quinn MT; Gildea JJ; Felder RA; Jose PA
    Redox Biol; 2014; 2():570-9. PubMed ID: 24688893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells.
    Brar SS; Corbin Z; Kennedy TP; Hemendinger R; Thornton L; Bommarius B; Arnold RS; Whorton AR; Sturrock AB; Huecksteadt TP; Quinn MT; Krenitsky K; Ardie KG; Lambeth JD; Hoidal JR
    Am J Physiol Cell Physiol; 2003 Aug; 285(2):C353-69. PubMed ID: 12686516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl.
    El Jamali A; Valente AJ; Lechleiter JD; Gamez MJ; Pearson DW; Nauseef WM; Clark RA
    Free Radic Biol Med; 2008 Mar; 44(5):868-81. PubMed ID: 18160052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma.
    Kalatskaya I
    Ann N Y Acad Sci; 2016 Oct; 1381(1):74-91. PubMed ID: 27415609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.
    Hansel DE; Dhara S; Huang RC; Ashfaq R; Deasel M; Shimada Y; Bernstein HS; Harmon J; Brock M; Forastiere A; Washington MK; Maitra A; Montgomery E
    Am J Surg Pathol; 2005 Mar; 29(3):390-9. PubMed ID: 15725809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.